MKI67 and neoplasm: The immunofluorescence staining for Ki67, a widely used marker of proliferation in human tumour cells, further confirmed this finding by revealing no significant differences between the percentage of Ki67-positive cells in the control and AGK2-treated conditions (Figure S8A,B).